PEPT (Regenerex Pharma) Pre-Tax Income : $-3.63 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerex Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Regenerex Pharma's pretax income for the three months ended in Jun. 2024 was $-0.27 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was $-3.63 Mil. Regenerex Pharma's pretax margin was %.

Regenerex Pharma Pre-Tax Income Historical Data

The historical data trend for Regenerex Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerex Pharma Pre-Tax Income Chart

Regenerex Pharma Annual Data

Trend

Nov10

Nov11

Nov12

Nov13

Nov14

Mar17

Mar18

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

-0.05

-0.19

-0.14

-3.54

Regenerex Pharma Quarterly Data
	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Pre-Tax Income	Get a 7-Day Free Trial															-0.19	-2.80	-0.26	-0.29	-0.27

Competitive Comparison of Regenerex Pharma's Pre-Tax Income

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Pre-Tax Income falls into.

Regenerex Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Regenerex Pharma's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.466	+	0.003	+	-0.081	+	0	+	0
	=	-3.54

Regenerex Pharma's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.254	+	0.004	+	-0.022	+	0	+	-0.001
	=	-0.27

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.63 Mil.

Regenerex Pharma (OTCPK:PEPT) Pre-Tax Income Explanation

Regenerex Pharma's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.273	/	0
	=	%

Regenerex Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Regenerex Pharma Inc (OTCPK:PEPT) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108

Website

https://regenerexpharmainc.com

Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the Company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Regenerex Pharma Headlines

No Headlines